Nephros Inc (OQ:NEPH)

Business Focus: Purification & Treatment Equipment

Mar 07, 2024 04:15 pm ET
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31,...
Feb 29, 2024 04:30 pm ET
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial results on...
Nov 08, 2023 04:15 pm ET
Nephros Announces Results for Quarter Ended September 30, 2023
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2023....
Nov 01, 2023 07:30 am ET
Nephros Hires Judy Krandel as Chief Financial Officer
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, announced the appointment of Judy Krandel as Chief Financial Officer (CFO), effective today....
Oct 25, 2023 07:30 am ET
Nephros Schedules Third Quarter 2023 Financial Results Conference Call
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November...
Sep 19, 2023 04:30 pm ET
Nephros to Present at LD Micro Main Event XVI
South Orange, New Jersey--(Newsfile Corp. - September 19, 2023) - Nephros, Inc. (NASDAQ: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will be presenting at the 16th annual Main Event on Tuesday, October 3rd at 9:00 AM PT at the Luxe Sunset Boulevard Hotel. Robert Banks, President & CEO, will be giving the presentation.
Aug 09, 2023 04:15 pm ET
Nephros Announces Results for Quarter Ended June 30, 2023
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2023. Financial...
Jul 26, 2023 07:30 am ET
Nephros Schedules Second Quarter 2023 Financial Results Conference Call
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Wednesday, August 9,...
May 24, 2023 07:30 am ET
Nephros to Present at LD Micro Invitational XIII
South Orange, New Jersey--(Newsfile Corp. - May 24, 2023) - Nephros, Inc. (NASDAQ: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that Andy Astor, Advisor and Interim Chief Financial Officer of Nephros, has been selected to present at the LD Micro Invitational XIII on Wednesday June 7, 2023 at 9:00am PT at the Luxe Sunset Boulevard Hotel in Los Angeles.
May 10, 2023 04:15 pm ET
Nephros Announces Results for Quarter Ended March 31, 2023
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the first quarter ended March 31, 2023. Financial...
May 08, 2023 07:30 am ET
Nephros Announces CEO Retirement and Succession Plan
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that Andy Astor, President and Chief Executive Officer, will retire in the...
Apr 26, 2023 07:30 am ET
Nephros Schedules First Quarter 2023 Financial Results Conference Call
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 10,...
Apr 04, 2023 07:30 am ET
Nephros Announces Preliminary Results for First Quarter 2023
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced preliminary revenue results for the quarter ended March 31, 2023. Nephros...
Mar 08, 2023 04:15 pm ET
Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31,...
Mar 01, 2023 04:30 pm ET
Nephros and Donastar Announce Strategic Partnership
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced a new partnership engaging Donastar Enterprises LLC as the exclusive master...
Feb 22, 2023 04:30 pm ET
Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced it will file its fourth quarter and fiscal 2022 results on Wednesday, March...
Jan 11, 2023 07:30 am ET
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced preliminary revenue results for the fourth quarter and fiscal year ended...
Nov 02, 2022 04:15 pm ET
Nephros Announces Results for Quarter Ended September 30, 2022
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2022. Financial...
Oct 19, 2022 07:30 am ET
Nephros Third Quarter 2022 Financial Results Conference Call
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November...
Oct 12, 2022 07:30 am ET
Nephros to Present at LD Micro Main Event XV
South Orange, New Jersey--(Newsfile Corp. - October 12, 2022) - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros has been selected to present at the LD Micro Main Event XV on Tuesday October 25, 2022 at 9:30am PT at the Luxe Sunset Boulevard Hotel in Los Angeles.
Oct 11, 2022 07:30 am ET
Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it has entered into a definitive agreement to sell...
Sep 28, 2022 07:30 am ET
Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced it has shipped 3,000 commercial water filters as part...
Sep 08, 2022 04:00 pm ET
Nephros Appoints Joe Harris to Its Board of Directors
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced the appointment of Joe Harris to its Board of...
Aug 10, 2022 04:15 pm ET
Nephros Announces Results for Quarter Ended June 30, 2022
via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30,...
Jul 27, 2022 07:30 am ET
Nephros Second Quarter 2022 Financial Results Conference Call
via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results...
Jul 06, 2022 07:30 am ET
Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary revenue results for the second quarter...
May 17, 2022 07:30 am ET
Nephros Receives FDA 510(k) Clearance for HDF Assist Module
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it has received FDA 510(k) clearance for its...
May 04, 2022 04:15 pm ET
Nephros Announces Results for Quarter Ended March 31, 2022
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for the first quarter ended March 31,...
Apr 27, 2022 07:30 am ET
Nephros First Quarter 2022 Financial Results Conference Call
via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results...
Apr 26, 2022 07:30 am ET
Nephros Unveils New Branding and Website
via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced the launch of a rebrand and new website. These changes...
Mar 21, 2022 07:30 am ET
Nephros to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of...
Feb 28, 2022 07:30 am ET
Nephros to Present at Q1 Virtual Investor Summit
South Orange, New Jersey--(Newsfile Corp. - February 28, 2022) - Nephros, Inc. (NASDAQ: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros will be attending the Q1 Virtual Investor Summit. During the Presentation, Mr. Astor will provide an overview of the business and its growth prospects.
Feb 23, 2022 04:15 pm ET
Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results
via NewMediaWire --Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year...
Feb 09, 2022 07:30 am ET
Nephros Fourth Quarter 2021 Financial Results Conference Call
via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its fourth quarter financial results...
Jan 13, 2022 07:30 am ET
Nephros Issues 2022 Shareholder Letter
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today issued a 2022 letter to shareholders. Dear Shareholder, We...
Jan 11, 2022 07:30 am ET
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary results for the fiscal year ended December...
Nov 23, 2021 04:15 pm ET
Nephros to Present at the Benchmark Company 10th Annual One-on-One Discovery Conference
via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of...
Nov 08, 2021 07:30 am ET
Nephros to Present at the Q4 Virtual Investor Summit
South Orange, New Jersey--(Newsfile Corp. - November 8, 2021) - Nephros, Inc. (NASDAQ: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros will be attending the Q4 Virtual Investor Summit. During the Presentation, Mr. Astor will provide an overview of the business and its growth prospects.
Nov 04, 2021 04:15 pm ET
Nephros Announces Results for Quarter Ended September 30, 2021
via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced results for the three months ended September 30, 2021....
Oct 21, 2021 07:30 am ET
Nephros Announces Third Quarter 2021 Financial Results Conference Call
via NewMediaWire – Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its third quarter financial results on...
Oct 08, 2021 07:30 am ET
Nephros Announces Preliminary Results for Third Quarter of 2021
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary results for the third quarter of 2021....
Oct 05, 2021 07:30 am ET
Nephros to Present at the LD Micro Main Event
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced it has been selected to present at...
Sep 15, 2021 09:39 am ET
Nephros to Present at the Virtual MicroCap Leadership Summit
via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced it has been selected to present at the 6th...
Sep 01, 2021 07:30 am ET
Nephros Appoints Wes Lobo to Chief Commercial Officer
via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced the appointment of Wes Lobo to the role of...
Aug 05, 2021 04:15 pm ET
Nephros Announces Results for Quarter Ended June 30, 2021
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading biotechnology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced results for the three months ended June 30,...
Jul 12, 2021 07:30 am ET
Nephros Announces Acquisition of GenArraytion, Inc.
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it has acquired substantially all of the assets of...
Jul 09, 2021 04:17 pm ET
Nephros CEO Presenting at Access to Giving Virtual Investor Conference
via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, has been invited to present at the Access to Giving Virtual Investor...
Jul 08, 2021 11:20 am ET
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meetings with qualified investors throughout the event.
Jul 08, 2021 07:30 am ET
Nephros Announces Preliminary Results for Second Quarter of 2021
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary results for the second quarter of 2021....
Jun 23, 2021 09:35 am ET
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified investors throughout the three-day event.
May 06, 2021 04:15 pm ET
Nephros Announces Results for Quarter Ended March 31, 2021
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced results for the three months ended March 31, 2021....
Apr 26, 2021 07:30 am ET
Nephros Announces First Quarter 2021 Financial Results Conference Call
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company, today announced that it will file its first quarter financial results on Thursday, May 6, 2021 after market close and will host a conference call that same day...
Apr 05, 2021 07:30 am ET
Nephros Announces Preliminary Results for First Quarter of 2021
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary results for the first quarter of 2021....
Mar 16, 2021 07:45 am ET
Nephros to Present at the Q1 Virtual Investor Summit
via InvestorWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executive Officer, has been...
Mar 10, 2021 07:30 am ET
Nephros to Participate in M-Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executive Officer, has been...
Mar 01, 2021 04:15 pm ET
Nephros Reports 2020 Fourth Quarter and Full Year Financial Results
via NewMediaWire -- Nephros, Inc. (Nasdaq:NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for the fourth quarter and full year...
Feb 22, 2021 07:30 am ET
Nephros Announces Fourth Quarter and Full Year 2020 Financial Results Conference Call
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its fourth quarter and full year...
Feb 18, 2021 07:30 am ET
Nephros Hires Wes Lobo as Chief Marketing Officer
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced the appointment of Wes Lobo as Chief Marketing...
Jan 12, 2021 07:30 am ET
Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company (“Nephros”) that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced...
Jan 05, 2021 10:55 am ET
Update: Nephros Provides Year-End Technology Update, Including HDF Program Status
via NewMediaWire--Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company  (“Nephros”) that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today provides an...
Jan 04, 2021 07:30 am ET
Nephros Provides Year-End Technology Update, Including HDF Program Status
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company (“Nephros”) that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today provides an...
Nov 19, 2020 06:45 am ET
Sidoti Virtual Microcap Investor Conference
NEW YORK, NY / ACCESSWIRE / November 19, 2020 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for today's Virtual Microcap Investor Conference.
Nov 09, 2020 07:30 am ET
Nephros to Present at Three November Investment Conferences
via NewMediaWire --Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will...
Nov 05, 2020 04:26 pm ET
Nephros Appoints Dan D’Agostino as CFO and Reports Third Quarter Financial Results
via NewMediaWire -- Nephros, Inc. (Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that Dan...
Oct 29, 2020 07:30 am ET
Nephros Announces Third Quarter 2020 Financial Results Conference Call
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will...
Oct 16, 2020 07:30 am ET
Nephros Announces Pricing of $5 Million Registered Direct Offering of Common Stock
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial...
Oct 13, 2020 07:30 am ET
Nephros Announces Release of DialyPath™, a qPCR-based, Real-time, On-site Endotoxin Assay for Dialysis Water
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced availability of...
Oct 08, 2020 03:30 pm ET
The MicroCap Rodeo Best Ideas Bowl 2020; October 13-16, 2020
NEW YORK, NY / ACCESSWIRE / October 8, 2020 / The MicroCap Rodeo continues this year with its first virtual event set for October 13-16, 2020. This year' "Best Ideas" conference focuses solely on 25 public companies recommended by institutional investors and qualified individual investors. The event will feature 2 days of company presentations followed by 2 days of pre-scheduled 1-1's.
Oct 07, 2020 07:30 am ET
Nephros to Present at MicroCap Rodeo Best Ideas Bowl on October 13th at 11:30 AM ET
via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it has been...
Oct 06, 2020 07:30 am ET
Nephros Announces Preliminary Third Quarter Revenues of $2.1 Million
via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced preliminary...
Aug 31, 2020 05:00 pm ET
(LD Micro) 360 Companies Set to Present this Week
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
Aug 25, 2020 07:30 am ET
Nephros to Present at the LD 500 Virtual Conference
Presentation on Tuesday, September 1st at 10:20am ET
Aug 14, 2020 07:30 am ET
Nephros Names Andy Astor President and Chief Executive Officer
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq:NEPH), a commercial-stage company that develops and sells water purification products and pathogen detection systems to the medical and commercial markets, today announced that Andy Astor, currently the...
Aug 05, 2020 04:15 pm ET
Nephros Reports Second Quarter Financial Results
Net Revenue down 32% due to COVID-19 Interruptions via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and...
Aug 05, 2020 09:00 am ET
LD Micro - Announces Preliminary List of Presenters for the LD 500
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
Jul 29, 2020 07:30 am ET
Nephros Announces Second Quarter 2020 Financial Results Conference Call
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will file its second...
Jul 22, 2020 07:30 am ET
Potable Water in Buildings Unoccupied During COVID-19 Pandemic Contains Far More Bacteria than in Occupied Buildings; Legionella does not Predominate
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq:NEPH), a commercial-stage company that develops and sells water purification products and pathogen detection systems to the medical and commercial markets, today announced the results of a study of water in...
Jul 16, 2020 11:00 am ET
'Zooming with LD' to Feature 10 Distinct Companies July 20th-31st
LOS ANGELES, CA / ACCESSWIRE / July 16, 2020 / LD Micro today announced that it will be hosting ten companies over the final two weeks of July, with a group presentation in the morning, followed by private investor meetings throughout the day.
Jul 13, 2020 07:30 am ET
Nephros to Present at Zooming with LD
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will be...
Jul 08, 2020 07:30 am ET
Nephros Announces Preliminary Financial Results for Second Quarter 2020
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced preliminary...
Jun 18, 2020 07:30 am ET
Nephros Set to Join Russell Microcap® Index
via NEWMEDIAWIRE -- Nephros, Inc.(Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it is set to...
Jun 03, 2020 09:00 am ET
47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th
NEW YORK, NY / ACCESSWIRE / June 3, 2020 / The Virtual Summer Summit will take place on June 9th-12th, connecting 47 presenting small and microcap companies with distinguished investors from around the globe. A full list of issuers are listed below along with webcasting links to view presentations.
Jun 02, 2020 07:30 am ET
Nephros to Present at the Virtual Summer Summit
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will be...
May 11, 2020 04:15 pm ET
Nephros, Inc. to Hold Virtual Annual Meeting of Stockholders
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH) announced today that, due to the public health concerns associated with the ongoing coronavirus outbreak and to support the health and well-being of its stockholders, employees, and other partners,...
May 06, 2020 04:15 pm ET
Nephros Reports First Quarter Financial Results
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced financial results...
Apr 29, 2020 07:30 am ET
Nephros Announces First Quarter 2020 Financial Results Conference Call
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will...
Apr 02, 2020 07:30 am ET
Nephros Announces Preliminary Financial Results for First Quarter 2020
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced preliminary...
Mar 25, 2020 07:30 am ET
Specialty Renal Products Announces Appointment of Tony Robinson as Vice President of Operations
via NEWMEDIAWIRE -- Specialty Renal Products, Inc. (SRP), a subsidiary of Nephros, Inc. (Nasdaq:NEPH), a medical device company that develops and sells a hemodiafiltration (HDF) system for the treatment of patients with end stage renal disease...
Mar 10, 2020 07:30 am ET
Nephros to Present at the Sidoti Spring 2020 Investor Conference
via NEWMEDIAWIRE -- Nephros, Inc.(Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will be...
Mar 04, 2020 04:45 pm ET
Nephros, Inc to Present at the Spring Investor Summit on March 25th-26th in New York City
NEW YORK, NY / ACCESSWIRE / March 4, 2020 / Nephros, Inc (Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial markets, will be presenting at this year's Spring Investor Summit on March 25th-26th in New York City.
Mar 03, 2020 07:30 am ET
Nephros to Present at the 2020 LD Micro Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / March 3, 2020 / Nephros, Inc. (Nasdaq:NEPH), a commercial stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets today, announced that it will be presenting at the third annual LD Micro Virtual Conference on Wednesday, March 4th, 7:20am PST/10:20am EST. Daron Evans, President and CEO of Nephros, will be giving the presentation and answering questions from investors.
Feb 27, 2020 04:05 pm ET
Nephros Reports 2019 Fourth Quarter and Full Year Financial Results
Nephros, Inc. (Nasdaq:NEPH), a commercial stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced financial results for the fourth...
Feb 20, 2020 07:30 am ET
Nephros Announces Fourth Quarter and Full Year 2019 Financial Results Conference Call
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will...
Jan 31, 2020 07:30 am ET
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a  commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial...
Jan 09, 2020 07:30 am ET
Nephros Announces Launch of PluraPath™, a Real-Time, Portable, Water Pathogen Detection System
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial markets, today announced that it...
Jan 06, 2020 07:30 am ET
Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2019
via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced preliminary financial results for the...
Nov 06, 2019 07:30 am ET
Nephros Reports Third Quarter Financial Results
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq:NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced financial results for the three months...
Oct 31, 2019 07:30 am ET
Nephros Announces Third Quarter 2019 Financial Results Conference Call
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced that it will file its third quarter 2019...
Oct 14, 2019 07:30 am ET
Nephros, Inc. (Nasdaq: NEPH) to Ring The Nasdaq Stock Market Closing Bell
via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets, will visit the Nasdaq MarketSite in Times Square. In...
Oct 07, 2019 07:30 am ET
Nephros Announces Preliminary Financial Results for Third Quarter 2019
via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced preliminary financial results for the...
Sep 03, 2019 07:30 am ET
Nephros Announces Presentations at Five Upcoming Investor Conferences
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced presentations at five upcoming investor...
Aug 13, 2019 07:30 am ET
Nephros Announces Listing on Nasdaq Capital Market
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced that its common shares have been approved...
Jul 30, 2019 01:32 pm ET
Update - Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPHD), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced that it will publish its second quarter...
Jul 30, 2019 07:30 am ET
Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced that it will publish its second quarter...
Jul 10, 2019 10:31 am ET
Nephros Announces Temporary Ticker Symbol Following Reverse Stock Split
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPHD), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced that its common stock will trade on the...
Jul 09, 2019 04:05 pm ET
Nephros Announces Preliminary Financial Results for Second Quarter 2019 and Reverse Stock Split
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced preliminary financial results for the...
May 16, 2019 07:30 am ET
Nephros Announces $2 Million Private Placement
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB:NEPH) (the “Company”), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced that it has completed a...
May 08, 2019 04:05 pm ET
Nephros Reports First Quarter Financial Results
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced financial results for the three months...
May 01, 2019 04:00 pm ET
Nephros Appoints Tom Gwydir to its Board of Directors
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage company that develops and sells high-performance water purification products to the medical device and commercial markets, today announced the appointment of Tom Gwydir to its...
May 01, 2019 07:30 am ET
Nephros to Report First Quarter 2019 Financial Results on May 8, 2019
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that it will issue its first quarter 2019 financial results...
Apr 25, 2019 09:30 am ET
Taglich Brothers Initiates Coverage of Nephros, Inc.
Taglich Brothers, Inc. announces that it has initiated coverage of Nephros, Inc. (Other: NEPH). Nephros Inc., headquartered in South Orange, NJ, is a water purification company that develops and sells high performance filters and ultrafilters...
Apr 24, 2019 07:30 am ET
Nephros to Present at Taglich Brothers 16th Annual Investment Conference on April 30, 2019 in New York City
via NEWMEDIAWIRE -- Nephros, Inc.(OTCQB: NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both medical device and commercial markets, today announced that Daron Evans, CEO and Andy Astor,...
Apr 08, 2019 07:30 am ET
Nephros Announces Preliminary Financial Results for First Quarter 2019
via NEWMEDIAWIRE – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device and commercial products company that develops and sells high performance water purification products, today announced preliminary financial results for the quarter...
Mar 29, 2019 07:45 am ET
Nephros to Present at the Spring Investor Summit on April 1st in New York City
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both medical device and commercial markets, today announced that Andy Astor, CFO will be presenting...
Mar 12, 2019 07:45 am ET
Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both medical device and commercial markets, today announced financial results for the three months and full year ended...
Mar 06, 2019 04:15 pm ET
Nephros to Report Fourth Quarter and Year End 2018 Financial Results on March 12th, 2019
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that it will issue its fourth quarter and year-end 2018 financial...
Feb 11, 2019 07:30 am ET
Nephros Appoints Alisa Lask to its Board of Directors
via NEWMEDIAWIRE – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced the appointment of Alisa Lask to its Board of Directors....
Jan 09, 2019 07:30 am ET
Nephros Announces Preliminary Financial Results for Fiscal Year 2018
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced preliminary financial results for fiscal year 2018. Total...
Jan 02, 2019 07:30 am ET
Nephros Announces Acquisition of Biocon
via NEWMEDIAWIRE – Nephros, Inc. (OTCQB: NEPH) (“Nephros”), a commercial stage company that develops and sells high performance liquid purification ultrafilters, today announced that it has acquired Biocon 1, LLC and its affiliate Aether Water...
Dec 03, 2018 07:30 am ET
Nephros to Present at the 11th Annual LD Micro Main Event
via NEWMEDIAWIRE – Nephros, Inc. (OTCQB: NEPH) (“Nephros”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that its executive management will present at the 11th...
Nov 08, 2018 04:10 pm ET
Nephros Reports Third Quarter 2018 Financial Results
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH) (“Nephros”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced financial results for the three months ended September...
Nov 01, 2018 07:30 am ET
Nephros to Report Third Quarter 2018 Financial Results on November 8th, 2018
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced that it will issue its third quarter 2018 financial results...
Oct 01, 2018 09:14 am ET
UPDATE: Nephros Announces Preliminary Financial Results for Third Quarter 2018
via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced preliminary financial results for the third quarter of 2018....
Oct 01, 2018 07:30 am ET
Nephros Announces Preliminary Financial Results for Third Quarter 2018
via NEWMEDIAWIRE - Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, today announced preliminary financial results for the third quarter of 2018....
Sep 06, 2018 07:30 am ET
Specialty Renal Products Announces $3 Million Series A Financing
via NEWMEDIAWIRE -- Specialty Renal Products, Inc. (SRP), a private medical device company focused on the development of products for patients with renal disease, including a hemodiafiltration (HDF) system for the treatment of patients with End...
Aug 14, 2018 07:30 am ET
Nephros Subsidiary Specialty Renal Products and HemoCleanse Announce License Agreement for Dialysate Filtration System
Specialty Renal Products, Inc. (SRP), a subsidiary of Nephros, Inc. (OTCQB:NEPH), a medical device company that develops and sells a hemodiafiltration system for the treatment of patients with End Stage Renal Disease (ESRD), and HemoCleanse...
Aug 13, 2018 07:30 am ET
Nephros Appoints Oliver Spandow to its Board of Directors
Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters announced today the appointment of Oliver Spandow to its Board of Directors. Mr. Spandow is...
Aug 08, 2018 04:10 pm ET
Nephros Reports Second Quarter 2018 Financial Results
Nephros, Inc. (OTCQB: NEPH) (“Nephros”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD)...
Aug 03, 2018 08:00 am ET
Nephros Schedules Second Quarter Financial Results Conference Call
Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (HDF) system for use with a hemodialysis (HD) machine for...
Jul 09, 2018 07:30 am ET
Nephros Announces Preliminary Financial Results for Second Quarter 2018
Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (HDF) system for use with a hemodialysis (HD) machine for...
Jun 04, 2018 07:45 am ET
Nephros to Present at 8th Annual LD Micro Invitational
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (HDF) system for use with a hemodialysis (HD) machine for...
May 09, 2018 07:45 am ET
Nephros Reports First Quarter 2018 Financial Results
Nephros, Inc. (OTCQB: NEPH) (“Nephros”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD)...
Apr 16, 2018 07:45 am ET
Nephros Announces Preliminary Financial Results for First Quarter 2018
Anticipates 39% Year-over-Year Product Revenue Growth; Reiterates $6 million 2018 Revenue Target
Apr 11, 2018 07:30 am ET
Nephros Announces $2.9 Million Private Placement
SOUTH ORANGE, NJ, April 11, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (HDF) system for use with a...
Feb 26, 2018 08:10 am ET
Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Annual Revenues Up 65% and Cash Flow from Operations Approaches Breakeven
Jan 23, 2018 07:30 am ET
Nephros to Present at NobleCon14
SOUTH ORANGE, N.J., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (HDF) system for use with a...
Jan 04, 2018 07:30 am ET
Nephros Announces Preliminary Financial Results for Fourth Quarter 2017
Anticipates Over 80% Year-over-Year Product Revenue Growth for the Quarter
Dec 13, 2017 07:30 am ET
Nephros Receives $1.8 Million in Cash from Sale of Tax Credits
SOUTH ORANGE, NJ, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a...
Nov 09, 2017 07:30 am ET
Nephros Reports Third Quarter 2017 Financial Results
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), today announced financial results for the three months ended September 30, 2017.
Nov 06, 2017 07:30 am ET
Nephros Announces Approval of $1.9 Million in NJEDA NOL Program Tax Credits
Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), announced today the receipt of $1.9 million in tax credit certificates from New Jersey Economic Development Authority (NJEDA), which are expected be sold later this quarter for over $1.75 million in net proceeds.
Oct 16, 2017 07:30 am ET
Nephros Provides Corporate Update and Announces Preliminary Third Quarter 2017 Revenue
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), is providing a general update on the Company's activities and guidance for the third quarter of 2017.
Aug 08, 2017 04:01 pm ET
Nephros Reports Second Quarter Financial Results and Receives NJEDA Approval for Approximately $1.5 million in Funding from Sale of Tax Credits
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), announced financial results for the three months ended June 30, 2017. The Company also announced that it has received approval to sell a percentage of its net operating losses ("NOLs") and research and development tax credits under The Technology Business Tax Certificate
Jul 10, 2017 07:30 am ET
Nephros Provides Corporate Update and Second Quarter 2017 Revenue Guidance
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), is providing a general update on the Company's activities and guidance for the second quarter of 2016.
Jun 09, 2017 08:00 am ET
Nephros to Present at Marcum 2017 MicroCap Conference
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), today announced that Andrew Astor, Chief Financial Officer, will present at the Marcum MicroCap Conference on Thursday June 15, 2017 at 4:00pm ET. The conference is being held at the Grand Hyatt Hotel, New York City. Management will also be available to meet with investors
May 09, 2017 07:30 am ET
Nephros Reports 2017 First Quarter Financial Results and Provides Corporate Update
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF") system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced today financial results for the three months ended March 31, 2017.
Apr 24, 2017 07:31 am ET
Nephros Announces Partnership with WorldWater & Solar Technologies
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, and WorldWater & Solar Technologies, Inc., a leader in integrated solar platform technology that uses sunshine to drive motors and pumps in large-scale irrigation and municipal water delivery systems, jointly announced today that they have signed a partnership agreement to incorporate Nephros ultrafilters into their solar powered drinking water systems.
Mar 20, 2017 05:44 pm ET
Nephros Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF") system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced today financial results for the three months and full year ended December 31, 2016.
Mar 17, 2017 08:30 am ET
Nephros Announces $1.2 Million Private Placement
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), today announced that it has entered into definitive agreements to sell 4,059,994 shares of common stock at a purchase price of $0.30 per share to institutional and accredited investors. In connection with the offering, the investors will also receive warrants to purchase up to
Mar 06, 2017 07:30 am ET
Nephros Receives FDA 510(k) Clearance of EndoPur(TM) Endotoxin 10" Filter
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF") system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") to market its EndoPur™ Endotoxin 10" Filter.
Feb 16, 2017 06:27 pm ET
Nephros to Present at the SeeThruEquity 3nd Annual Innovations Investor Conference on Feb. 22, 2016
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), will present at the SeeThruEquity 3nd Annual Innovations Investor Conference at The W Hotel in Miami on South Beach on February 22, 2017.
Feb 14, 2017 07:30 am ET
Nephros Announces Appointment of Andrew Astor as Chief Financial Officer
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), announced today that it had hired Andrew Astor as Chief Financial Officer.
Jan 24, 2017 07:30 am ET
Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), is providing a general update on the Company's activities and guidance for the fourth quarter of 2016.
Dec 27, 2016 09:25 am ET
Nephros Receives FDA 510(k) Clearance of HydraGuard(TM) 10" UltraFilter
Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF") system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") to market its HydraGuard™ 10" UltraFilter.
May 11, 2016 04:20 pm ET
Nephros Reports First Quarter 2016 Financial Results
Nephros, Inc. (OTCQB: NEPH), (the "Company") a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF") system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced today financial results for the three months ended March 31, 2016.
Mar 30, 2016 08:41 am ET
Nephros Reports 2015 Fourth Quarter and Full Year Financial Results; Provides Guidance and Potential Upcoming Milestones
Nephros, Inc. (OTCQB: NEPH), (the "Company") a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration ("HDF") system for use with a hemodialysis machine for the treatment of patients with end stage renal disease, announced today financial results for the three months and full year ended December 31, 2015.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.